G2GBIO456160
G2GBIO (456160) Material Information, Oct 19, 2026
Filing date ·
G2GBIO said it signed a platform evaluation agreement with China-based pharmaceutical company UBT on October 19, 2026 to assess the potential for developing a…
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.